Piperidine derivatives

US8765959B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Gerald Juergen Roth · Biberach, DE
• Martin Fleck · Warthausen, DE
• Bernd Nosse · Biberach an der Riß, DE
• Thorsten Lehmann-Lintz · Ochsenhausen, DE

Key dates

• Filing date: Dec 14, 2012
• Grant date: Jul 1, 2014
• Expiry date: Dec 14, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Piperidine derivatives of which the following is exemplaryand their use in the treatment of obesity, diabetes or dyslipidemia.